ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/07/31 | 4,790 | 4,940 | 4,760 | 4,890 | +30 | +0.6% | 435,700 |
2019/07/30 | 4,690 | 4,880 | 4,665 | 4,860 | +225 | +4.9% | 379,800 |
2019/07/29 | 4,685 | 4,750 | 4,600 | 4,635 | -25 | -0.5% | 398,000 |
2019/07/26 | 4,375 | 4,680 | 4,360 | 4,660 | +225 | +5.1% | 542,500 |
2019/07/25 | 4,335 | 4,435 | 4,210 | 4,435 | +55 | +1.3% | 325,800 |
2019/07/24 | 4,455 | 4,535 | 4,375 | 4,380 | +40 | +0.9% | 403,000 |
2019/07/23 | 4,185 | 4,400 | 4,185 | 4,340 | +90 | +2.1% | 196,800 |
2019/07/22 | 4,305 | 4,335 | 4,135 | 4,250 | -125 | -2.9% | 303,800 |
2019/07/19 | 4,240 | 4,425 | 4,235 | 4,375 | +145 | +3.4% | 413,900 |
2019/07/18 | 4,170 | 4,260 | 4,125 | 4,230 | +20 | +0.5% | 229,300 |
2019/07/17 | 4,065 | 4,220 | 4,005 | 4,210 | +105 | +2.6% | 228,000 |
2019/07/16 | 4,230 | 4,290 | 3,950 | 4,105 | -80 | -1.9% | 530,800 |
2019/07/12 | 4,000 | 4,230 | 3,940 | 4,185 | +185 | +4.6% | 471,500 |
2019/07/11 | 3,990 | 4,030 | 3,905 | 4,000 | +45 | +1.1% | 245,800 |
2019/07/10 | 3,900 | 4,010 | 3,830 | 3,955 | +35 | +0.9% | 278,100 |
2019/07/09 | 3,850 | 4,010 | 3,835 | 3,920 | +80 | +2.1% | 335,900 |
2019/07/08 | 3,875 | 3,915 | 3,720 | 3,840 | -5 | -0.1% | 269,100 |
2019/07/05 | 3,625 | 3,845 | 3,575 | 3,845 | +215 | +5.9% | 241,600 |
2019/07/04 | 3,630 | 3,685 | 3,585 | 3,630 | +40 | +1.1% | 200,700 |
2019/07/03 | 4,030 | 4,030 | 3,485 | 3,590 | -90 | -2.4% | 880,800 |
2019/07/02 | 3,585 | 3,715 | 3,545 | 3,680 | +90 | +2.5% | 361,500 |
2019/07/01 | 3,395 | 3,650 | 3,315 | 3,590 | +125 | +3.6% | 538,700 |
2019/06/28 | 3,180 | 3,620 | 3,140 | 3,465 | +305 | +9.7% | 778,600 |
2019/06/27 | 3,200 | 3,235 | 3,100 | 3,160 | -10 | -0.3% | 146,700 |
2019/06/26 | 3,000 | 3,170 | 2,999 | 3,170 | +130 | +4.3% | 177,900 |
2019/06/25 | 3,095 | 3,140 | 3,015 | 3,040 | -80 | -2.6% | 147,600 |
2019/06/24 | 3,170 | 3,200 | 3,085 | 3,120 | +5 | +0.2% | 108,000 |
2019/06/21 | 3,115 | 3,210 | 3,060 | 3,115 | +10 | +0.3% | 289,200 |
2019/06/20 | 2,907 | 3,120 | 2,907 | 3,105 | +199 | +6.8% | 319,300 |
2019/06/19 | 2,850 | 2,938 | 2,847 | 2,906 | +104 | +3.7% | 207,200 |
2019/06/18 | 2,780 | 2,876 | 2,780 | 2,802 | +29 | +1% | 164,400 |
2019/06/17 | 2,850 | 2,850 | 2,764 | 2,773 | -79 | -2.8% | 123,700 |
2019/06/14 | 2,755 | 2,855 | 2,718 | 2,852 | +111 | +4% | 207,400 |
2019/06/13 | 2,786 | 2,786 | 2,711 | 2,741 | -45 | -1.6% | 104,000 |
2019/06/12 | 2,798 | 2,858 | 2,785 | 2,786 | -17 | -0.6% | 106,400 |
2019/06/11 | 2,730 | 2,807 | 2,721 | 2,803 | +70 | +2.6% | 92,900 |
2019/06/10 | 2,718 | 2,776 | 2,718 | 2,733 | +32 | +1.2% | 112,500 |
2019/06/07 | 2,709 | 2,718 | 2,660 | 2,701 | +20 | +0.7% | 120,800 |
2019/06/06 | 2,725 | 2,738 | 2,681 | 2,681 | -53 | -1.9% | 129,800 |
2019/06/05 | 2,748 | 2,773 | 2,712 | 2,734 | +36 | +1.3% | 143,600 |
2019/06/04 | 2,699 | 2,738 | 2,608 | 2,698 | +15 | +0.6% | 215,400 |
2019/06/03 | 2,772 | 2,783 | 2,665 | 2,683 | -172 | -6% | 205,500 |
2019/05/31 | 2,921 | 2,953 | 2,846 | 2,855 | -92 | -3.1% | 151,300 |
2019/05/30 | 2,902 | 2,986 | 2,880 | 2,947 | +19 | +0.6% | 176,100 |
2019/05/29 | 2,932 | 2,950 | 2,852 | 2,928 | -54 | -1.8% | 220,100 |
2019/05/28 | 2,860 | 2,984 | 2,829 | 2,982 | +170 | +6% | 384,900 |
2019/05/27 | 2,795 | 2,832 | 2,772 | 2,812 | +4 | +0.1% | 145,800 |
2019/05/24 | 2,719 | 2,819 | 2,703 | 2,808 | +45 | +1.6% | 146,000 |
2019/05/23 | 2,788 | 2,795 | 2,703 | 2,763 | -52 | -1.8% | 178,200 |
2019/05/22 | 2,716 | 2,825 | 2,710 | 2,815 | +139 | +5.2% | 224,100 |
1401~
1450
件表示中 / 3687件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 223,700円 | +21.7% | +999.9% | 0.00% | 9.32倍 | 3.08倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 232,500円 | +14.2% | +41.0% | 1.98% | 11.39倍 | 1.16倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 311,000円 | +3.0% | +27.5% | 2.57% | 19.69倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 149,500円 | +8.8% | +99.9% | 3.48% | 9.54倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 225,100円 | +0.4% | -8.4% | 2.35% | 28.90倍 | 1.63倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム